The global primary cells market size was valued at USD 955.0 million in 2020 and is expected to grow at a CAGR of 8.4% during the forecast period. The primary cell culture market is experiencing growth owing to the increasing geriatric population, rising cases of chronic diseases, and advancements in research and development. The pharmaceutical market worldwide is attracting significant investments for advanced drug development and testing.
了解有关此报告的更多信息:request for sample pages
主要细胞广泛用于诸如的应用中3.D cell culture,病毒学,癌症研究,干细胞疗法和组织更换等。研究人员越来越多地利用用于3D细胞培养的产品来分析细胞生物学和生物化学,药物,细胞信号传导和细胞和病原体相互作用的影响。
制药部门用途用于检查药物的细胞毒性,生物分子的产生和疫苗发育。主要细胞的使用防止使用动物模型用于生产疫苗。可以通过主要细胞检测和分离病毒以分析感染模式。
Growth Drivers
There has been a rising occurrence of cancer and associated disorders, thereby increasing the adoption of primary product. Primary cells are imparted cancerous properties through exposure to chemicals and radiation for analysis of drug performance, signaling pathways, and side effects of treatments. Genetically engineered proteins such as insulin andmonoclonal antibodies也可以通过主要细胞开发。
The increasing adoption of stem cell therapy for the treatment of cancer and genetic disorders has increased the demand for primary cells across the globe. Primary cell cultures are used for the development of cells for tissue regeneration or replacement of deficient cells.
预计主要细胞培养市场将受到技术进步,癌症相关疾病的上升案例等因素的推动,以及越来越需要为治疗癌症和遗传疾病而越来越多的需求。越来越多的单克隆抗体要求,生长在基因工程和病毒学以及发展中国家的需求上升正在推动市场增长。
全球各国政府正在推出支持原发性细胞文化市场的增长的规定。全球主要细胞文化市场也受中国,日本和印度等国家经济增长的影响,医疗保健和药品支出。yabo娱乐vip全球参与者正在扩展到这些国家以挖掘市场潜力,进一步推动市场增长。
该市场主要根据来源,类型,最终用途和地区进行分段。
By Source |
By Type |
通过最终使用 |
按地区 |
|
|
|
|
了解有关此报告的更多信息:request for sample pages
在来源的基础上,市场被分段为动物和人类。由于全世界癌症病例的显着增长,人类原发性细胞分部占主要份额。人的原代细胞提供了能够产生生理相关数据的优异细胞培养系统。对于各种应用,诸如药物发现,基因治疗和癌症研究等各种应用的人类来源的需求越来越需要增加其需求。
The type market segment has been divided into hematopoietic, hepatocytes, renal cells, gastrointestinal cells, skin cells, lung cells, and others. The hematopoietic cells accounted for a major share of the global primary cell culture market. Increasing application in cancer-based research, toxicology screening programs, drug development, and environmental testing has increased the demand for these cells. The growing adoption of hematopoietic cells instem cell therapy进一步推动其需求。
On the basis of end-use, the market is segmented into medical, pharmaceutical & biotechnology companies, research institutes, and others. Pharmaceutical and biotechnology companies are increasingly using of the product for pharmaceutical drug discovery to address genetic and autoimmune disorders, injury, and inflammation. Pharmaceutical companies also use primary cells for cytotoxicity of new drugs and drug carriers. The market demand for primary cells has increased from this segment as a replacement for animal testing models for testing new drugs and chemicals.
北美在2020年占据了全球原发性小区市场。癌症和相关疾病的发生日益增长,日益增长的研究和开发活动以及技术进步是归因于该区域细分的增长的一些因素。既定的医疗保健基础设施和越来越多yabo娱乐vip的研究投资,技术创新和临床试验驱动了该地区的增长。公共私人合作的进步生物技术and biopharmaceutical sectors further supplement the growth of the primary cell culture market.
主要小区市场中的领先球员包括Cell Biologics,Inc。,Zenbio,Inc。,Stem Cell Technologies,Sigma-Aldrich,Thermo Fisher Scientific,Celline,美国型文化收集,细胞应用,Inc。,Pelobiotech,Merck Kgaa,Axol Bioscience Ltd,Promocell,Allcells,Lonza Group,AG和Creative Bioarray。